These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12037505)

  • 1. [Rosiglitazone: clinical data].
    Blickle JF
    Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 2):1S27-33. PubMed ID: 12037505
    [No Abstract]   [Full Text] [Related]  

  • 2. Rosiglitazone in combination with glimepiride plus metformin in type 2 diabetic patients.
    Kiayias JA; Vlachou ED; Theodosopoulou E; Lakka-Papadodima E
    Diabetes Care; 2002 Jul; 25(7):1251-2. PubMed ID: 12087036
    [No Abstract]   [Full Text] [Related]  

  • 3. Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naïve patients: response to Rosenstock et al.
    Hamid Z; Simmons DL
    Diabetes Care; 2006 Oct; 29(10):2331; author reply 2332. PubMed ID: 17003324
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combination therapy with biguanides].
    Sakura H
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():724-8. PubMed ID: 12430309
    [No Abstract]   [Full Text] [Related]  

  • 5. Using dose-response characteristics of therapeutics agents for treatment decisions in type 2 diabetes.
    Garber AJ
    Diabetes Obes Metab; 2000 Jun; 2(3):139-47. PubMed ID: 11220549
    [No Abstract]   [Full Text] [Related]  

  • 6. Pioglitazone and rosiglitazone for diabetes.
    Drug Ther Bull; 2001 Sep; 39(9):65-8. PubMed ID: 11586802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus.
    Bressler R; Johnson DG
    Arch Intern Med; 1997 Apr; 157(8):836-48. PubMed ID: 9129543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Diabetes Federation meeting, 1997. Issues in the treatment of type 2 diabetes; sulfonylureas, metformin, and troglitazone.
    Bloomgarden ZT
    Diabetes Care; 1998 Jun; 21(6):1024-6. PubMed ID: 9614626
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of insulin alone and in combination with oral agents in type 2 diabetes.
    Buse JB
    Prim Care; 1999 Dec; 26(4):931-50. PubMed ID: 10523468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosiglitazone for type 2 diabetes mellitus.
    Med Lett Drugs Ther; 1999 Aug; 41(1059):71-3. PubMed ID: 10603986
    [No Abstract]   [Full Text] [Related]  

  • 11. Rosiglitazone and cardiotoxicity--weighing the evidence.
    Nathan DM
    N Engl J Med; 2007 Jul; 357(1):64-6. PubMed ID: 17551161
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combination therapy of insulin sensitizer, thiazolidinedione drugs, and sulfonylurea].
    Ohmura E; Hosaka D; Imai Y; Kawazu S
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():470-5. PubMed ID: 12387036
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination therapy in type 2 diabetes: the role of repaglinide.
    Moses R
    J Assoc Physicians India; 2001 Jan; 49 Spec No():62-8. PubMed ID: 11235608
    [No Abstract]   [Full Text] [Related]  

  • 14. Rosiglitazone + glimepiride: new drug. Another combination product to avoid.
    Prescrire Int; 2007 Aug; 16(90):144. PubMed ID: 17726795
    [No Abstract]   [Full Text] [Related]  

  • 15. Insulin initiation in Type 2 diabetes.
    Page S
    Diabet Med; 2005 Sep; 22 Suppl 4():2-5. PubMed ID: 16109011
    [No Abstract]   [Full Text] [Related]  

  • 16. Rosiglitazone/glimepiride (Avandaryl) for diabetes.
    Med Lett Drugs Ther; 2006 Mar; 48(1230):22-4. PubMed ID: 16538189
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy decision based on the glucose triad. Drug treatment of type 2 diabetes].
    Hanefeld M; Fischer S
    MMW Fortschr Med; 2003 Feb; 145(9):30-4. PubMed ID: 12666526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiazolidinedione derivatives in type 2 diabetes mellitus.
    Tack CJ; Smits P
    Neth J Med; 2006 Jun; 64(6):166-74. PubMed ID: 16788214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetes mellitus].
    Kawano M; Kanazawa Y
    Nihon Rinsho; 2000 Feb; 58(2):421-5. PubMed ID: 10707569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Type 2 diabetes mellitus: Which place for thiazolidinediones in the therapeutic strategy?].
    Halimi S
    Diabetes Metab; 2001 Apr; 27(2 Pt 2):287-93. PubMed ID: 11452223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.